DYANN MINTON: Open Payments
NPI 1013603950 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $866 · 2025 $336
Food & beverage: $334Education: $2
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $140 |
| Amgen Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Ardelyx, Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $2 |
Products named: JYNARQUE, TAVNEOS, KRYSTEXXA, Kerendia, VOYXACT, CRYSVITA, ULTOMIRIS, Veltassa.
Industry payments across TX — which companies pay providers there.
